India, Oct. 30 -- The shares of the Small-cap company, which specializes in manufacturing and marketing a diverse portfolio of generic and specialty pharmaceutical formulations, are in the spotlight after rallying 20 percent in today's trade on its Q2 results.

With a market capitalization of Rs. 1,481.77 crores in the day's trade, the shares of Bharat Parenterals Ltdhit a 20 percent upper circuit, reaching a high of Rs. 2,292.15 per share compared to its previous closing price of Rs. 1,910.15 per share.

Q2 Results Revenue from Operations increased by 109.2 percent YoY, from Rs. 65 crore in Q2 FY26 to Rs. 136 crore in Q2 FY27. It also increased by 44.7 percent QoQ, from Rs. 94 crore in Q1 FY27 to Rs. 136 crore in Q2 FY27.

The company ...